Literature DB >> 24898641

Baseline predictors of cognitive decline in patients with cerebral small vessel disease.

Aleksandra M Pavlovic1, Tatjana Pekmezovic1, Gordana Tomic1, Jasna Zidverc Trajkovic1, Nada Sternic1.   

Abstract

INTRODUCTION: Cerebral small vessel disease (SVD) is a common cause of cognitive impairment and vascular dementia.
OBJECTIVE: We aimed to investigate predictors of cognitive decline in patients with SVD who initially presented with first-ever small subcortical stroke of lacunar type but had normal cognitive status.
METHODS: A total of 294 patients with SVD were evaluated 3-5 years after initial presentation. We analyzed baseline demographic data, vascular risk factors, functional status expressed as score on modified Rankin Scale, total number of lacunar infarcts, and severity of white matter hyperintensities (WMH) on magnetic resonance imaging with Age-Related White Matter Changes scale total score (tARWMC) and Fazekas scale periventricular and deep subcortical scores.
RESULTS: At follow-up, vascular cognitive impairment (VCI) on any type was detected in 188 (63.9%) of SVD patients, with 65 (22.1%) meeting criteria for vascular dementia and 123 (41.8%) presenting with cognitive impairment not dementia. Patients with VCI were older (64.4 ± 10.3 in VCI versus 58.6 ± 10.5 years in non-VCI; p < 0.0001) at the time of initial clinical presentation and more frequently male (57.9% VCI versus 46.2% non-VCI; p = 0.052). No difference was noted in frequency of vascular risk factors in VCI versus non-VCI cases. Multivariate logistic regression analysis adjusted by age and gender identified overall severity of WMH (tARWMC HR 1.42, 95% CI 1.01-2.00; p0.043) and total number of lacunar infarcts (HR 3.06, 95% CI 1.71-5.50, p < 0.001) as independent predictors of cognitive decline.
CONCLUSION: In patients with SVD, independent predictors of VCI were baseline severity of WMH and total number of lacunar infarcts.

Entities:  

Keywords:  Lacunar infarct; small vessel disease; stroke; vascular cognitive impairment; white matter hyperintensities

Mesh:

Year:  2014        PMID: 24898641     DOI: 10.3233/JAD-132606

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.472


  12 in total

1.  Cognitive profiles in degenerative dementia without evidence of small vessel pathology and small vessel vascular dementia.

Authors:  Antonella De Carolis; Virginia Cipollini; Nicole Donato; Micaela Sepe-Monti; Francesco Orzi; Franco Giubilei
Journal:  Neurol Sci       Date:  2016-09-21       Impact factor: 3.307

Review 2.  Cognitive impairment in patients with cerebrovascular disease: A white paper from the links between stroke ESO Dementia Committee.

Authors:  Ana Verdelho; Joanna Wardlaw; Aleksandra Pavlovic; Leonardo Pantoni; Olivier Godefroy; Marco Duering; Andreas Charidimou; Hugues Chabriat; Geert Jan Biessels
Journal:  Eur Stroke J       Date:  2021-02-28

3.  Relationship Between White Matter Hyperintensities Penumbra and Cavity Formation.

Authors:  Xiaoyu Zhang; Lingling Ding; Lei Yang; Wei Qin; Yue Li; Shujuan Li; Wenli Hu
Journal:  Med Sci Monit       Date:  2016-01-05

4.  Total Cerebral Small Vessel Disease MRI Score Is Associated with Cognitive Decline in Executive Function in Patients with Hypertension.

Authors:  Renske Uiterwijk; Robert J van Oostenbrugge; Marjolein Huijts; Peter W De Leeuw; Abraham A Kroon; Julie Staals
Journal:  Front Aging Neurosci       Date:  2016-12-12       Impact factor: 5.750

5.  Range in systolic blood pressure and care-needs certification in long-term care insurance in community-dwelling older patients with chronic kidney disease.

Authors:  Taroh Himeno; Tazuo Okuno; Keisuke Watanabe; Kumie Nakajima; Osamu Iritani; Hiroshi Yano; Takuro Morita; Yuta Igarashi; Masashi Okuro; Shigeto Morimoto
Journal:  J Int Med Res       Date:  2017-08-23       Impact factor: 1.671

6.  Cerebral Small Vessel Disease: A Review Focusing on Pathophysiology, Biomarkers, and Machine Learning Strategies.

Authors:  Elisa Cuadrado-Godia; Pratistha Dwivedi; Sanjiv Sharma; Angel Ois Santiago; Jaume Roquer Gonzalez; Mercedes Balcells; John Laird; Monika Turk; Harman S Suri; Andrew Nicolaides; Luca Saba; Narendra N Khanna; Jasjit S Suri
Journal:  J Stroke       Date:  2018-09-30       Impact factor: 6.967

7.  Protocol: The Lacunar Intervention Trial 2 (LACI-2). A trial of two repurposed licenced drugs to prevent progression of cerebral small vessel disease.

Authors:  Joanna Wardlaw; Philip M W Bath; Fergus Doubal; Anna Heye; Nikola Sprigg; Lisa J Woodhouse; Gordon Blair; Jason Appleton; Vera Cvoro; Timothy England; Ahamad Hassan; David John Werring; Alan Montgomery
Journal:  Eur Stroke J       Date:  2020-04-20

8.  Increased risk of cognitive impairment and more severe brain lesions in hypertensive compared to non-hypertensive patients with cerebral small vessel disease.

Authors:  Aleksandra M Pavlovic; Tatjana Pekmezovic; Jasna Zidverc Trajkovic; Gordana Tomic; Edita Cvitan; Nada Sternic
Journal:  J Clin Hypertens (Greenwich)       Date:  2018-07-29       Impact factor: 3.738

Review 9.  Cognitive Function: Is There More to Anticoagulation in Atrial Fibrillation Than Stroke?

Authors:  Lin Cao; Sean D Pokorney; Kathleen Hayden; Kathleen Welsh-Bohmer; L Kristin Newby
Journal:  J Am Heart Assoc       Date:  2015-08-03       Impact factor: 5.501

10.  Trial of remote ischaemic preconditioning in vascular cognitive impairment (TRIC-VCI): protocol.

Authors:  Aravind Ganesh; Philip Barber; Sandra E Black; Dale Corbett; Thalia S Field; Richard Frayne; Vladimir Hachinski; Zahinoor Ismail; Lauren M Mai; Cheryl R McCreary; Demetrios Sahlas; Mukul Sharma; Richard H Swartz; Eric E Smith
Journal:  BMJ Open       Date:  2020-10-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.